INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial
(NASDAQ: INMB) Delayed: 1.24 -0.03 (2.36%)
Previous Close $1.27    52 Week High $ 
Open $1.28    52 Week Low $ 
Day High $1.31    P/E N/A 
Day Low $1.24    EPS $ 
Volume 149,546